SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-000318
Filing Date
2023-01-03
Accepted
2023-01-03 09:06:32
Documents
3
Group Members
IRIS PURCHASER INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d442488dsctota.htm SC TO-T/A 21857
2 EX-99.(A)(5)(E) d442488dex99a5e.htm EX-99.(A)(5)(E) 16708
3 GRAPHIC g442488g29h59.jpg GRAPHIC 3996
  Complete submission text file 0001193125-23-000318.txt   45905
Mailing Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 106 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Subject) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91186 | Film No.: 23500490
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filed by) CIK: 0001792044 (see all company filings)

IRS No.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations